GERN

Geron Corporation

Price

$1.59

return (12m)

11.19%

p/e

-14.64

p/bv

4.53

DIVIDEND YIELD

0.00%

GERN price

Geron

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GERN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

8.16%

3 months

26.19%

1 year

11.19%

2 years

-64.35%

5 years

21.37%

10 years

-41.97%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals GERN

Valuation

P/E

-14.64

Sector -4.38

Industry -4.38

P/BV

4.53

Sector 2.02

Industry 2.02

P/Revenue (PSR)

4.84

Sector -4.40

Industry -4.40

EV/EBITDA

-87.94

Sector -263.09

Industry -263.09

EV/EBIT

-84.89

Sector -702.90

Industry -702.90

P/EBITDA

-27.39

Sector -4.39

Industry -4.39

P/EBIT

-26.48

Sector -4.73

Industry -4.73

P/Total Assets

1.91

Sector 1.49

Industry 1.49

P/Net Current Assets

5.32

Sector -11.70

Industry -11.70

P/Working Capital

2.38

Sector -3.19

Industry -3.19

EPS

-0.10

Sector -2.14

Industry -2.14

BVPS

0.33

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

93.50%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-16.01%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-16.58%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-17.25%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-33.05%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.11

Sector 0.03

Industry 0.03

Profitability

ROE

-30.93%

Sector -65.14%

Industry -65.14%

ROA

-13.03%

Sector -65.53%

Industry -65.53%

ROIC

-27.44%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.92

Sector 2.90

Industry 2.90

Net Debt / EBITDA

19.64

Sector -6.07

Industry -6.07

Net Debt / EBIT

18.96

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.83

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.55

Sector -0.05

Industry -0.05

Equity/Assets

0.42

Sector 0.41

Industry 0.41

Liabilities/Assets

0.58

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

170.98%

Sector -

Industry -

5Y Earnings CAGR

-10.25%

Sector -

Industry -

Fundamentals GERN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
GERN Geron Corporation	$1.59	10.42%	0.00%	-14.64	4.53	-30.93%	-33.05%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GERN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Geron

Geron Corporation

Average Investor10 user rating

4.0 (0 people)

United States

36 years

Founded: 1990

1996

Time since IPO - 30 years

55

Employees

Geron Corporation (United States) is listed on the Nasdaq and has a market capitalization of $989.73 million, with shareholders equity totaling $218.61 million.

The company employs approximately 55 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Geron Corporation reported $204.57 million in revenue, generating net income of $-67.61 million.

Key financial metrics include a P/E ratio of -14.64, a price-to-book (P/B) ratio of 4.53, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker GERN.

Market cap

$989.73 million

Net worth

$218.61 million

$218,610,000.00

Assets

$519.01 million

$519,010,000.00

Total Shares Outstanding

671.00 million

671,000,000

Average Daily Trading Volume

$12.35 million

$12,350,680.46

Sector

Health Care

Industry

Biotechnology

GERN

GERN revenue and profits

Financial Results GERN

DRAG THE FRAME TO SEE MORE DATA

GERN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Geron (GERN) today?

A cotação de Geron (GERN) hoje está em US$ 1.59, com uma variação de 11.19% em relação ao último ano. A cotação de Geron (GERN) iniciou o ano negociando na casa dos US$ 1.32 e hoje está em US$ 1.59. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Geron (GERN) e dados de ações do Ibovespa e mercados internacionais.

Quando Geron (GERN) paga dividendos?

Geron (GERN) não distribuiu dividendos no último ano.

Is Geron (GERN) a good investment?

Atualmente, Geron (GERN) está cotada a US$ 1.59, com um P/L de -14.64, representando um desvio de -1,032% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 11.19 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 11.19%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Geron (GERN) stock?

Investir em ações de Geron (GERN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Geron (GERN) yield today?

A rentabilidade de Geron (GERN) foi de 8.16% no último mês, 11.19% no último ano e 21.37% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Geron (GERN) hoje, o investimento total seria de US$ 159.00, com base na cotação atual de US$ 1.59.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 176.79
Em 5 anos: US$ 192.98
Em 10 anos: US$ 92.27

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

GERN

Geron Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment GERN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING GERN WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Geron

Geron Corporation

United States

36 years

1996

55

PROFIT X PRICE GERN

Financial Results GERN

GERN cash flow

Asset, Revenue and Profit Growth - GERN

GERN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions